home / stock / nby / nby news


NBY News and Press, NovaBay Pharmaceuticals Inc. From 03/28/22

Stock Information

Company Name: NovaBay Pharmaceuticals Inc.
Stock Symbol: NBY
Market: NYSE
Website: novabay.com

Menu

NBY NBY Quote NBY Short NBY News NBY Articles NBY Message Board
Get NBY Alerts

News, Short Squeeze, Breakout and More Instantly...

NBY - Notable earnings after Tuesday's close

AMPE, AREC, CALM, CHWY, CRMD, CWBR, CWCO, HTGM, INFI, OTCQB:LQMT, LULU, MLKN, MOTS, MU, MVST, NBRV, NBY, OTC:OIBZQ, OPGN, PAVM, PRGS, PVH, RH, SNDL, SPWH, SUNL, VRNT, ZVO For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesd...

NBY - NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2021 after market close on Tuesday, March 29, 2022 and will hold an investment community conference call that day beginning at...

NBY - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! Let’s start off the final day of the workweek right with a breakdown of the biggest pre-market stock movers for Friday! Source: Shutterstock The biggest news moving stocks this morning a...

NBY - NovaBay stock rises 14% on launch of HA Serum

NovaBay Pharmaceuticals (NYSE:NBY) launched Moisture Recovery HA Serum as the newest expansion to its Calm Cool + Corrected product line. The company said Moisture Recovery HA Serum is a formulation of hyaluronic acid, Vitamin C, Dragon Fruit and water-binding cactus botanicals to restore par...

NBY - DERMAdoctor Launches New HA Serum to Expand Calm Cool + Corrected Product Line

New oil-free moisturizer is formulated with hyaluronic acid (HA), Vitamin C and unique botanical boosters to hydrate and repair the most challenged, dry, eczema-prone skin NovaBay® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and ...

NBY - NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Present DERMAdoctor Eczema Treatment as QVC® On-Air Guest

Calm Cool + Corrected Eczema + Dermatitis Clinical Repair Balm to be Featured in Premier Show on March 1 at 10 p.m. Eastern Time NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality, scientifically formulat...

NBY - NovaBay engages marketing firm for DERMAdoctor skincare products in China

NovaBay Pharmaceuticals (NYSE:NBY) is collaborating with a Chinese marketing firm for omnichannel integrated marketing and branding services of DERMAdoctor skincare products in China. The company's marketing partner will also manage DERMAdoctor’s online flagship store on Tmall.com, a l...

NBY - NovaBay Pharmaceuticals Engages Leading Chinese Marketing Firm to Drive Consumer Sales of DERMAdoctor Skincare Products in China

New marketing partner to provide omnichannel integrated marketing and branding services including managing DERMAdoctor’s flagship retail store on Tmall.com, the leading B2C online retailer in China NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a ...

NBY - NovaBay Pharmaceuticals Announces Changes to Its Board of Directors

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces the appointments of Audrey Kunin, M.D. and Julie Garlik...

NBY - NovaBay Pharmaceuticals to Donate 2.5 Million KN95 Masks

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated products for the eyecare and skincare markets, announces its commitment to donate 2.5 million KN95 protective mas...

Previous 10 Next 10